Exportació completada — 
Carregant...

Peginterferon β-1a every 2 weeks increased achievement of no evidence of disease activity over 4 years in the ADVANCE and ATTAIN studies in patients with relapsing–remitting multiple sclerosis

BACKGROUND: No evidence of disease activity (NEDA) is a composite measurement, incorporating clinical and magnetic resonance imaging (MRI) elements of disease activity to sensitively evaluate the therapeutic efficacy of treatments for relapsing–remitting multiple sclerosis (RRMS). OBJECTIVE: To asse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Neurol Disord
Autors principals: Arnold, Douglas L., Shang, Shulian, Dong, Qunming, Meergans, Matthias, Naylor, Maria L.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6113732/
https://ncbi.nlm.nih.gov/pubmed/30181780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286418795085
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!